GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the catalytic domain of human MMP12 in complex with selective phosphinic inhibitor RXP470A

Analyse Crystal structure of the catalytic domain of human MMP12 in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4GR3
Type
protein
Length
159 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Macrophage metalloelastase
EC
3.4.24.65
UniProt
P39900
Ligands
R45, CA, ZN
Pockets
2 · best druggability 0.56

Structure

x-ray diffraction · 1 distinct chain · 26% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMacrophage metalloelastase (EC 3.4.24.65)protein15926% helix, 17% strandP39900

Ligands and binding sites

  • R45 · N-{(2S)-3-[(S)-(4-bromophenyl)(hydroxy)phosphoryl]-2-[(3-phenyl-1,2-oxazol-5-yl)methyl]propanoyl}-L-alpha-glutamyl-L-al pha-glutamine · ligand · chains A
  • CA · Calcium ion · metal · 3 copies · chains A
  • ZN · Zinc ion · metal · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11520.560.8125R45
2770.340.7521empty

Compared structures

  • 4GR3 · Crystal structure of the catalytic domain of Human MMP12 in complex with selective… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.